Asepxia Acne

Description

Asepxia® Acne Lotion contains 1.86% salicylic acid and is indicated for the treatment of acne. This formulation penetrates pores to effectively eliminate most pimples and blackheads while helping to maintain clear skin and prevent new acne breakouts. The product is available in a 4 fluid ounce (118 ml) dosage form.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears acne blemishes, including acne pimples, blackheads, and whiteheads, while allowing the skin to heal. Additionally, it helps prevent the formation of new acne blemishes, pimples, blackheads, and whiteheads by penetrating the pores and eliminating most existing pimples and blackheads. This drug also aids in maintaining clear skin by reducing the occurrence of new acne breakouts.

No teratogenic or nonteratogenic effects have been mentioned.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The product should be applied as a thin layer to the entire affected area one to three times daily, depending on the patient's needs and the physician's recommendations.

For patients new to the product, it is advised to apply it sparingly to one or two small affected areas during the first three days of treatment. If no discomfort is experienced, the patient may then follow the standard application instructions.

To minimize the risk of excessive skin drying, it is recommended to initiate treatment with one application daily. If tolerated, the frequency may be gradually increased to two or three times daily. Should the patient experience bothersome dryness or peeling, the application frequency should be reduced to once daily or every other day, as appropriate.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid concurrent use of this product with other topical acne medications, as this may increase the risk of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to keep this product out of the reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is for external use only. The most commonly reported adverse reactions include skin irritation and dryness, particularly when used concurrently with other topical acne medications. The likelihood of experiencing these reactions increases when multiple topical treatments are applied simultaneously. In the event of irritation, it is recommended that patients limit their use to one topical acne medication at a time to mitigate these effects.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical acne medications and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Asepxia Acne (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this product. It is essential to keep the product out of the reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

To minimize the risk of excessive skin drying, it is recommended to initiate treatment with one application daily. Dosage may be gradually increased to two or three times daily as needed or directed by a healthcare professional. Should any bothersome dryness or peeling occur, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of Asepxia Acne Lotion during pregnancy, including safety concerns, dosage modifications, or any special precautions. Healthcare professionals should exercise caution when prescribing this medication to pregnant patients, as the lack of data precludes a comprehensive assessment of potential risks to fetal outcomes. Women of childbearing potential should be informed of the absence of established safety data and encouraged to discuss any concerns with their healthcare provider.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in lactating mothers. Additionally, there are no known data on excretion in breast milk or effects on breastfed infants. Healthcare professionals should consider the absence of specific guidance when advising lactating mothers on the use of this medication.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous monitoring of the patient's vital signs and clinical status is recommended to ensure appropriate interventions are implemented in a timely manner.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of the reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Additionally, it is important to inform patients that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. Healthcare providers should recommend that patients use only one topical acne medication at a time to minimize the risk of irritation. If patients experience any signs of irritation, they should be encouraged to discontinue use and consult their healthcare provider for further guidance.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the product from light exposure to maintain its integrity. The bottle should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Clinicians should advise patients that the product is for external use only and to be cautious of potential skin irritation and dryness, particularly if used concurrently with other topical acne medications. In such cases, it is recommended to limit the use to one topical acne medication at a time.

Patients should be counseled to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately if swallowed. New users are advised to perform a sensitivity test by applying the product sparingly to one or two small affected areas during the first three days; if no discomfort occurs, they may then proceed with the full application as directed.

Drug Information (PDF)

This file contains official product information for Asepxia Acne, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)